Thursday, 18 July 2019

Drug Discovery News

  • Ex-sanofi cancer head is PharmaEngine advisor

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corporate strategy, licensing and alliance management. Dr Herrera previousl...Read more

  • Cold Spring Harbor Lab uses cancer drugs to treat Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

    Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out research to show that a class of currently used anti-cancer drugs as w...Read more

  • Chugai expands in Singapore with research institute

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

    Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operations in Singapore on July 2, 2012. The opening ceremony was attended b...Read more

  • Australia invests in autoimmune disease start up firm

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and multip...Read more

  • François-Xavier Roge is Takeda's new CFO

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Novartis, Regenerex further immune tolerance R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a biopharmaceutical company based in Louisville, Kentucky, US, for use of...Read more

  • Boehringer Ingelheim appoints board member

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board of managing directors. The 52-year-old will take over the responsibi...Read more

  • China develops revolutionary TCM migraine medication

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

  • Novartis eye care firm gets EU nod for Jetrea

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal injection (ocriplasmin) in the EU for the tre...Read more

  • QRxPharma to resubmit NDA to FDA for pain relieving drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Application (NDA) for treatment of moderate to severe acute pain.With the iss...Read more

  • Gilead HIV/AIDS 'blood booster' gets EU nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobicistat 150 mg tablets), a pharmacokinetic enhancer that boosts blood ...Read more

  • Merck, AstraZeneca sign deal for cancer drug therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in phase IIa cli...Read more

  • Inversion of ibuprofen in body helps fight cancer: Study

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inflammatory drug ibuprofen might stop certain cancers from developing. ...Read more

  • Australia ideal for early-stage drug development

    Drug Discovery |  Opinion | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900s. This history includes a notable sprinkling of Nobel Prize winners,...Read more

  • HUYA, Sanzao Park partner for drug development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park. The ...Read more

  • GSK's cancer drug gets EU marketing authorization

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used in combination with trastuzumab. This combination is indicated for a...Read more

  • Astellas completes patient recruitment in drug trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE. Isavuconazole is an investigational intravenous (IV)...Read more

  • Daiichi Sankyo expands drug discovery program

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls